同心医疗、高凯技术上交所IPO“已问询”

Group 1: Tongxin Medical Technology Co., Ltd. - Tongxin Medical is a global innovative medical device company focused on advancing treatment for advanced heart failure through breakthrough technologies and solutions [1] - The company's first implantable full magnetic levitation left ventricular assist device, CH-VAD, has been approved for market entry in China, making it the first of its kind in the country [1] - The iterative version, CH-VAD Plus, is currently in the registration phase and is expected to be approved for market entry in China by early 2026 [1] - In the U.S. market, the next-generation implantable full magnetic levitation left ventricular assist device, BrioVAD, has received FDA approval to enter clinical trials, marking it as the first active implantable medical device from China to achieve this [1] Group 2: Gaokai Technology Co., Ltd. - Gaokai Technology specializes in the research, development, production, and sales of key control components and related equipment in the precision fluid control field [2] - The company's product lineup includes flow control series, dispensing and packaging series, and precision coating series, which have been continuously improved [2] - Gaokai's products are widely used in intelligent manufacturing sectors such as semiconductors, consumer electronics, automotive electronics, and new energy [2]